Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tumor vascular disrupting agent polypeptide, gene, expression vector, and use thereof

Tumor vascular disrupting agent polypeptide, gene, expression vector, and use thereof

US Patent 9896498 · Granted Feb 20, 2018

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Variable region sequence of broad-spectrum antibody against clothianidin and din2024
Ecological revetment for regulating wandering rivers2024
Preparation and application of an intact recombinant antibody specific to clothi2024
Substituted urea depsipeptide analogs as activators of the ClpP endopeptidase2020
Substituted urea depsipeptide analogs as activators of the ClpP endopeptidase2020
Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase2020
Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase2019
Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase2018
Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase2018
Antigen composition, preparation method and use thereof, and tumor vaccine2016
Relating to propylene oxide purification2016
Method and kit for detecting hepcidin2015